S CIENTIFIC PROGRAM
Thursday, June 29th, 2017
15.00 – 15.45
Registration desk open
15.45 – 16.00
Welcome address
E. Liberopoulos – K. Tziomalos
Coordinators of the Summer School
Welcome address
C. Pitsavos
President of the Hellenic Atherosclerosis Society
16.00 – 16.45
Clinical pharmacology of beta-blockers
G. Liamis (Ioannina, Greece)
Discussion with the participants on multiple choice questions
16.45 – 17.30
Clinical pharmacology of thiazide diuretics, loop diuretics and
aldosterone antagonists
D. Vlahakos (Athens, Greece)
Discussion with the participants on multiple choice questions
17.30 – 18.15
Clinical pharmacology of calcium channel blockers
V. Kotsis (Thessaloniki, Greece)
Discussion with the participants on multiple choice questions
18.15 – 18.45
Coffee break
18.45 – 19.30
Clinical pharmacology of angiotensin converting enzyme inhibitors
and angiotensin receptor blockers
K. Thomopoulos (Athens, Greece)
Discussion with the participants on multiple choice questions
19.30 – 20.15:
Clinical pharmacology of second line antihypertensive agents
A. Achimastos (Athens, Greece)
Discussion with the participants on multiple choice questions
20.15 – 21.00
Clinical pharmacology of old and newer agents for the
management of heart failure
C. Pitsavos (Athens, Greece)
Discussion with the participants on multiple choice questions
Friday, June 30th, 2017
09.00 – 09.45
Clinical pharmacology of statins
E. Ganotakis (Heraklion, Greece)
Discussion with the participants on multiple choice questions
09.45 - 10.30
Clinical pharmacology of ezetimibe, colesevelam and fibrates
K. Tziomalos (Thessaloniki, Greece)
Discussion with the participants on multiple choice questions
10.30 – 11.15
Clinical pharmacology of PCSK9 inhibitors
V. Athyros (Thessaloniki, Greece)
Discussion with the participants on multiple choice questions
11.15 – 11.45
Coffee break
11.45 – 12.30
Clinical pharmacology of inhibitors of COX-1 and
phosphodiesterases
A. Tselepis (Ioannina, Greece)
Discussion with the participants on multiple choice questions
12.30 – 13.15
Clinical pharmacology of platelet ADP-receptor antagonists
E. Bilianou (Athens, Greece)
Discussion with the participants on multiple choice questions
13.15 – 14.00
Cardiovascular disease prevention and lifestyle interventions
R. Estruch (Barcelona, Spain)
Discussion with the participants on multiple choice questions
14.00 – 15.00
Coffee break
15.00 – 15.45
Clinical pharmacology of acenocoumarol and injectable
anticoagulants
S. Tsiara (Ioannina, Greece)
Discussion with the participants on multiple choice questions
15.45 – 16.30
Clinical pharmacology of direct oral anticoagulants
C. Milionis (Ioannina, Greece)
Discussion with the participants on multiple choice questions
16.30 – 17.15
Clinical pharmacology of antidotes to anticoagulants
G. Ntaios (Larisa, Greece)
Discussion with the participants on multiple choice questions
17.15 – 17.30
Coffee break
17.30 – 18.15
Planning and organization of clinical trials
N. Nikas (Athens, Greece)
Discussion with the participants on multiple choice questions
18.15 – 19.00
Clinical pharmacology of antiobesity agents
A. Kokkinos (Athens, Greece)
Discussion with the participants on multiple choice questions
19.00 – 19.45
What is new in antidiabetes therapy and future challenges
M. Lehrke (Germany)
Discussion with the participants on multiple choice questions
19.45 – 20.00
Hypolipidemic drug therapy: challenges and directions
M. Banach (Lodz, Poland)
Discussion with the participants on multiple choice questions
Saturday, July 1st, 2017
09.00 – 9.45
Clinical pharmacology of metformin and sulfonylureas
S. Pappas (Athens, Greece)
Discussion with the participants on multiple choice questions
09.45 – 10.30
Clinical pharmacology of DPP-4 inhibitors and pioglitazone
A. Melidonis (Athens, Greece)
Discussion with the participants on multiple choice questions
10.30 – 11.15
Clinical pharmacology of GLP-1 analogs
Ε. Liberopoulos (Ioannina, Greece)
Discussion with the participants on multiple choice questions
11.15 – 11.45
Coffee break
11.45 – 12.30
Clinical pharmacology of SGLT2 inhibitors
M. Elisaf (Ioannina, Greece)
Discussion with the participants on multiple choice questions
12.30 – 13.15
Clinical pharmacology of basal insulin and basal insulin-GLP-1
analogs fixed combinations
V. Labadiari (Athens, Greece)
Discussion with the participants on multiple choice questions
13.15 – 14.00
Clinical pharmacology of prandial insulins and mixtures
G. Dimitriadis (Athens, Greece)
Discussion with the participants on multiple choice questions
14.00 – 15.00
Lunch break
15.00 – 15.45
Appropriate and inappropriate combinations of antidiabetic agents
S. Liatis (Athens, Greece)
Discussion with the participants on multiple choice questions
15.45 – 16.30
Clinical pharmacology of antiarrhythmic agents
P. Korantzopoulos (Athens, Greece)
Discussion with the participants on multiple choice questions
16.30 – 17.15
Clinical pharmacology of ivabradine and neprilysin inhibitors
C. Chrysohooou (Athens, Greece)
Discussion with the participants on multiple choice questions
17.15 – 18.00
Mistakes in statistical analysis in medical research
D. Panagiotakos (Athens, Greece)
Discussion with the participants on multiple choice questions
18.00 – 19:00
Excellence in Lipidology course exam
19.00
End of Summer School